Review
Open access
Sep 2026
Histone deacetylases in cancer metabolic reprogramming
It is suggested that developing isoform-specific HDAC inhibitors could enhance therapeutic precision, particularly in targeting cancer’s metabolic dependencies, pointing towards future research directions in cancer metabolism and epigenetics.
Yu Hyun Jeon, Hyeyeong Seo, J. Youn et al.
· Experimental and Molecular M... · 1 citation